Compare Lupin Ltd with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs WOCKHARDT - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN WOCKHARDT LUPIN/
WOCKHARDT
 
P/E (TTM) x 106.7 -21.0 - View Chart
P/BV x 2.4 1.1 218.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LUPIN   WOCKHARDT
EQUITY SHARE DATA
    LUPIN
Mar-19
WOCKHARDT
Mar-18
LUPIN/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs9861,012 97.4%   
Low Rs720532 135.5%   
Sales per share (Unadj.) Rs369.5355.9 103.8%  
Earnings per share (Unadj.) Rs13.4-60.3 -22.2%  
Cash flow per share (Unadj.) Rs37.4-46.8 -79.9%  
Dividends per share (Unadj.) Rs00.01 0.0%  
Dividend yield (eoy) %00 0.0%  
Book value per share (Unadj.) Rs303.7257.8 117.8%  
Shares outstanding (eoy) m452.49110.63 409.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.32.2 106.5%   
Avg P/E ratio x63.6-12.8 -497.1%  
P/CF ratio (eoy) x22.8-16.5 -138.3%  
Price / Book Value ratio x2.83.0 93.8%  
Dividend payout %00 0.0%   
Avg Mkt Cap Rs m386,06485,379 452.2%   
No. of employees `00017.76.3 282.8%   
Total wages/salary Rs m31,5139,371 336.3%   
Avg. sales/employee Rs Th9,453.86,295.0 150.2%   
Avg. wages/employee Rs Th1,782.01,498.3 118.9%   
Avg. net profit/employee Rs Th343.0-1,066.3 -32.2%   
INCOME DATA
Net Sales Rs m167,18239,369 424.7%  
Other income Rs m3,6401,202 302.8%   
Total revenues Rs m170,82240,571 421.0%   
Gross profit Rs m28,82218 157,498.4%  
Depreciation Rs m10,8501,495 725.6%   
Interest Rs m3,0782,555 120.5%   
Profit before tax Rs m18,534-2,830 -655.0%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,400-3,582 94.9%   
Tax Rs m9,017257 3,508.5%   
Profit after tax Rs m6,066-6,669 -91.0%  
Gross profit margin %17.20 37,088.7%  
Effective tax rate %48.7-9.1 -535.6%   
Net profit margin %3.6-16.9 -21.4%  
BALANCE SHEET DATA
Current assets Rs m138,53633,796 409.9%   
Current liabilities Rs m61,29926,917 227.7%   
Net working cap to sales %46.217.5 264.4%  
Current ratio x2.31.3 180.0%  
Inventory Days Days8479 105.6%  
Debtors Days Days11289 126.0%  
Net fixed assets Rs m127,51639,664 321.5%   
Share capital Rs m905553 163.6%   
"Free" reserves Rs m136,51727,968 488.1%   
Net worth Rs m137,42228,522 481.8%   
Long term debt Rs m66,41721,731 305.6%   
Total assets Rs m279,49481,620 342.4%  
Interest coverage x7.0-0.1 -6,529.9%   
Debt to equity ratio x0.50.8 63.4%  
Sales to assets ratio x0.60.5 124.0%   
Return on assets %3.3-5.0 -64.9%  
Return on equity %4.4-23.4 -18.9%  
Return on capital %8.9-7.7 -116.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m59,4149,807 605.8%   
Fx outflow Rs m22,2821,789 1,245.8%   
Net fx Rs m37,1328,019 463.1%   
CASH FLOW
From Operations Rs m16,660684 2,434.2%  
From Investments Rs m-32,8256,302 -520.8%  
From Financial Activity Rs m7,441-7,695 -96.7%  
Net Cashflow Rs m-8,724-664 1,313.8%  

Share Holding

Indian Promoters % 46.6 74.5 62.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 2.3 491.3%  
FIIs % 31.9 7.7 414.3%  
ADR/GDR % 0.0 0.1 -  
Free float % 10.1 15.4 65.6%  
Shareholders   98,259 67,757 145.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   IPCA LABS  NOVARTIS  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  SANOFI INDIA  

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Nov 11, 2019 (Close)

TRACK LUPIN

LUPIN - CIPLA COMPARISON

COMPARE LUPIN WITH

MARKET STATS